Medical Advocates
Week-in-Review: Jan 30-Feb-06, 2010
  Week-in-Review
  ...a weekly summary of  the most frequently accessed papers,
abstracts, posters, news, and reports featured on the Medical
Advocates' New and Noteworthy Web.

Medical Advocates' Web Weekly Utilization Data
 

Visits

4,311

  
Hits 24,751  
 

 
Main New/Newsworthy Home Page
This web page is best viewed by using INTERNET EXPLORER
All Citations are abstracts UNLESS OTHERWISE NOTED

  High prevalence of primary Enfuvirtide (ENF) resistance-associated mutations in
HIV-1-infected patients in Hong Kong.
Leung PH, Chen JH, Wong KH, et al
J Clin Virol. 2010 Jan 27.



 Enfuvirtide
 

  Etravirine: A novel nonnucleoside reverse transcriptase inhibitor for managing human
immunodeficiency virus infection.
Elsayed RK, Caldwell DJ.
Am J Health Syst Pharm. 2010 Feb 1;67(3):193-205.



 Etravirine
 

  Differences in liver fibrosis and response to pegylated interferon plus ribavirin in
HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
Maida I, Martin-Carbonero L, Sotgiu G, et al
J Viral Hepat. 2010 Jan 18



 Peginterferon
 
 

Factors predictive of successful darunavir/ritonavir-based therapy in highly
antiretroviral-experienced HIV-1-infected patients (the DARWEST study).
Delaugerre C, Buyck JF, Peytavin G, et al
 J Clin Virol. 2010 Jan 21
 

Darunavir
 
 

Inluenza surveillance in a cohort of HIV-infected children and adolescents immunized
against seasonal influenza.
Amendola A, Pariani E, Vigaṇ A, Erba P, et al
 Vaccine. 2010 Jan 24.

Adolescents
Children
 
  Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies:
The NISDI Perinatal Study.
 Joao EC, Calvet GA, Krauss MR, et al
J Acquir Immune Defic Syndr. 2010 Feb;53(2):176-185.



 Pregnant Women/Neonates
 

Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
 

Main New/Newsworthy Home Page

Week-in-Review